Floatz logo

Mocetinostat

Diffuse Large B-Cell Lymphoma and Follicular Lymphoma

Memorial Sloan Kettering Cancer CenterSmall moleculePhase 1/2Dormant
C
37/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
22/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Diffuse Large B-Cell Lymphoma and Follicular Lymphoma cohort.

Asset / SponsorPhaseRating

Same molecule, other indications

Mocetinostat is also rated in:

acute myeloid leukemiaDormant
CC
Indicative ·
47 / 100
View asset →
myelodysplastic syndromeDormant
CC
Indicative ·
47 / 100
View asset →
neoplasmDormant
CC
Indicative ·
47 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →